...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Chinese Takeovers
3
Mar 06, 2018 07:13PM

SF

Thanks for posting that article. Hepalink's >40% investment in RVX is perilously close to controlling RVX and it's IP.  A disconcerting situation. I trust that DM has the situation under control. 

Chicagoest   

1
Mar 06, 2018 10:42PM
3
Mar 07, 2018 10:32AM
1
Mar 07, 2018 10:49AM
4
Mar 07, 2018 12:56PM
4
Mar 07, 2018 01:15PM

Mar 07, 2018 03:56PM
4
Mar 07, 2018 08:02PM
3
Mar 07, 2018 10:58PM
3
Mar 08, 2018 03:59AM

Mar 08, 2018 09:49AM
2
Mar 08, 2018 11:53AM
2
Mar 08, 2018 12:54PM
Share
New Message
Please login to post a reply